Randomized, double-blind, multicenter trial comparing two doses of arzoxifene (LY353381) in hormone-sensitive advanced or metastatic breast cancer patients

  1. Baselga, J.
  2. Llombart-Cussac, A.
  3. Bellet, M.
  4. Guillem-Porta, V.
  5. Enas, N.
  6. Krejcy, K.
  7. Carrasco, E.
  8. Kayitalire, L.
  9. Kuta, M.
  10. Lluch, A.
  11. Vodvarka, P.
  12. Kerbrat, P.
  13. Namer, M.
  14. Petruzelka, L.
Aldizkaria:
Annals of Oncology

ISSN: 0923-7534

Argitalpen urtea: 2003

Alea: 14

Zenbakia: 9

Orrialdeak: 1383-1390

Mota: Berrikuspena

DOI: 10.1093/ANNONC/MDG368 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus